DIMETHYLSULFOXIDE
UkraineThe drug is used to treat inflammatory diseases of the musculoskeletal system (e.g., rheumatoid arthritis, ankylosing spondylitis, osteoarthritis), tendon sprains, injuries, osteomyelitis, pyogenic wounds, and abscesses. It is also used in surgery to promote the engraftment of transplanted skin.
Frequently asked questions
How should the drug be used correctly?
The drug is used externally in the form of compresses or tampons. A gauze pad soaked in a solution of the appropriate concentration is applied to the affected area (including the adjacent healthy skin) for 20–30 minutes once a day. A film and cloth should be placed over the gauze pad.
What are the contraindications for using Dimethylsulfoxide?
The drug must not be used in cases of hypersensitivity to it, cardiovascular diseases (angina pectoris, myocardial infarction, severe atherosclerosis, heart failure), renal or hepatic impairment, stroke, glaucoma, cataracts, or in comatose states. It should not be applied to damaged skin, allergic skin, or the face.
Can the drug be taken by pregnant women or children?
Use of the drug during pregnancy is contraindicated. Breastfeeding must be discontinued during treatment. The drug is not used in children under 12 years of age.
What are the possible side effects of Dimethylsulfoxide?
Possible allergic reactions (rash, itching, edema, redness, dry skin), nausea, vomiting, diarrhea, headache, dizziness, insomnia, weakness, or bronchospasm.
How does the drug interact with other substances?
Dimethylsulfoxide enhances the effects of alcohol, insulin, aspirin, antibiotics, and anesthetics. This may lead to an increase in both the efficacy and toxicity of these drugs. It also enhances the effects of digitalis preparations, nitroglycerin, and other specific agents.
What should be done if the drug gets into the eyes?
If the solution accidentally gets into the eyes, they must be rinsed immediately with running water.
Instructions for use
INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT DIMETHYLSULFOXIDE (DIMETHYLSULFOXID)
Composition:
Active substance: dimethylsulfoxide;
1 vial contains dimethylsulfoxide 50 ml or 100 ml.
Pharmaceutical form. Liquid for external use.
Main physicochemical properties: colorless liquid or colorless crystals. Hygroscopic.
Pharmacotherapeutic group.
Topical agents for joint and muscle pain.
ATC code M02AX03.
Pharmacological properties.
Pharmacodynamics.
Dimethyl sulfoxide has the ability to penetrate biological membranes, including skin barriers, thereby exerting its specific effects, which include anti-inflammatory, antipyretic, analgesic, antiseptic, and moderate fibrinolytic actions. The drug enhances the penetration through intact skin and mucous membranes of medicinal agents (transporting ability).
Pharmacokinetics.
After topical application of a 90% dimethyl sulfoxide solution to the skin, it appears in the blood within 5 minutes, reaching maximum concentration within 4–6 hours, with maintenance of almost unchanged levels for 1.5–3 days. Dimethyl sulfoxide is excreted in urine and feces both unchanged and as dimethyl sulfone.
Clinical characteristics.
Indications.
To be used as part of complex therapy for inflammatory diseases of the musculoskeletal system: rheumatoid arthritis, Bechterew's disease (ankylosing spondylitis), deforming osteoarthritis (in the presence of periarticular tissue involvement); in arthropathy, tendon strain due to trauma, traumatic infiltrates, acute and chronic osteomyelitis, streptoderma, purulent wounds, abscesses.
Also used in plastic surgery—for the grafting of transplanted skin autografts and homografts, as well as for the preservation of skin homografts.
Contraindications.
Hypersensitivity to the drug. Cardiovascular insufficiency, severe atherosclerosis, angina pectoris, myocardial infarction, impaired kidney or liver function, stroke, comatose states, glaucoma, cataract.
Interaction with other medicinal products and other types of interactions.
Dimethyl sulfoxide enhances the effects of ethanol (alcohol inhibits drug elimination) and insulin, acetylsalicylic acid, butadione; digitalis preparations, quinidine, nitroglycerin, antibiotics (streptomycin, monomycin, etc.), chloramphenicol, rifampicin, griseofulvin, and increases organism sensitivity to anesthetic agents. Enhanced specific activity as well as toxicity of medicinal agents due to the drug should be taken into account. May be used in combination with nonsteroidal anti-inflammatory agents in complex therapy of deforming osteoarthritis and rheumatoid arthritis; in combination with topical antimicrobial agents (synthomycin ointment)—for the treatment of streptoderma.
Special precautions for use.
Do not apply to damaged skin or skin with signs of allergy. Do not apply to the facial skin.
Before using the medicinal product, a sensitivity test must be performed. For this purpose, a small amount of the solution should be applied to the skin using a cotton swab. A sharp redness and itching of the skin after application of dimethyl sulfoxide indicate individual hypersensitivity to the drug.
Elderly patients may use the drug after prior consultation with a physician.
Avoid contact of the drug with mucous membranes and eyes. In case of accidental contact with eyes, immediately rinse them thoroughly with running water.
At temperatures below 18 °C, dimethyl sulfoxide may crystallize; this does not affect the quality of the drug. To dissolve the crystals, carefully warm the vial containing the drug in a water bath (water temperature approximately 60 °C). Do not boil!
Do not violate the instructions for use of the medicinal product, as this may harm health.
Use during pregnancy or breastfeeding.
The medicinal product is contraindicated during pregnancy. Breastfeeding should be discontinued during treatment with dimethyl sulfoxide.
Ability to influence reaction rate when driving or operating machinery.
Use with caution, considering the effect on the central nervous system, including the possibility of dizziness.
Method of administration and dosage.
Used as aqueous solutions (30–50% concentration) for compresses and tampons.
Gauze pads moistened with dimethyl sulfoxide solution are applied to affected areas, including adjacent healthy skin areas, for 20–30 minutes once daily. Over the pad, a polyethylene film is placed, followed by cotton or linen fabric.
For diffuse streptoderma, compresses with 40–90% dimethyl sulfoxide solution are recommended.
For purulent skin diseases, a 40% solution is used.
In dermato-plastic surgery, dressings with 10–20% solution of the drug are applied to transplanted skin autografts and homografts immediately after surgery and during subsequent postoperative days until stable graft take.
A 5% dimethyl sulfoxide solution in Ringer's solution is used as a preserving agent for storage of skin homografts.
Instructions for preparing aqueous solutions of the drug at the specified concentrations
| Concentration of the solution, % |
Quantity of the preparation in volume parts |
Quantity of water in volume parts |
| 10 20 30 40 50 90 |
1 1 3 2 1 9 |
9 4 7 3 1 1 |
Children.
Do not use the medicinal product in children under 12 years of age.
Overdose.
Overdose of dimethyl sulfoxide may cause allergic reactions (urticaria, edema) and intensification of adverse effects, requiring discontinuation of the medicinal product and administration of symptomatic therapy.
Adverse reactions.
Dimethyl sulfoxide is generally well tolerated, but in some patients the following may occur:
Immune system side effects: allergic reactions including dermatitis, skin rash, angioneurotic edema, itching, burning, skin hyperemia, erythema, skin dryness.
Gastrointestinal tract side effects: nausea, vomiting, diarrhea.
Central and peripheral nervous system side effects: headache, dizziness, insomnia, adynamia.
Respiratory system side effects: bronchospasm.
Shelf life. 3 years.
Storage conditions.
Store in original packaging at a temperature not exceeding 25 °C.
Keep out of reach of children.
Packaging.
50 ml or 100 ml in glass or polymer bottles.
Availability category. Over-the-counter (without prescription).
Manufacturer.
LLC "MEDLEV".
Manufacturer's address and place of business.
171 Bohdana Khmelnytskoho St., Bldg. B-1, K-1, Dnipro, 49000, Ukraine.
Similar drugs
| Brand name | Dosage form | Active substance / Dosage | Manufacturer |
|---|---|---|---|
| DIMEXID | liquid, for external use |
|
JSC "Lubnipharm" |
| DIMEXID-JFF | liquid, for external use |
|
DKP "Pharmaceutical Factory" LLC |
The original data is available in the language of the country of manufacture.
Data source: State Register of Medicinal Products of Ukraine
Data last verified: August 13, 2026